Marc Becker
2019 - Concert Pharmaceuticals
In 2019, Marc Becker earned a total compensation of $1.9M as Chief Financial Officer at Concert Pharmaceuticals, a 23% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $157,320 |
|---|---|
| Option Awards | $1,039,225 |
| Salary | $393,300 |
| Stock Awards | $288,515 |
| Other | $9,060 |
| Total | $1,887,420 |
Becker received $1M in option awards, accounting for 55% of the total pay in 2019.
Becker also received $157.3K in non-equity incentive plan, $393.3K in salary, $288.5K in stock awards and $9.1K in other compensation.
Rankings
In 2019, Marc Becker's compensation ranked 6,228th out of 13,971 executives tracked by ExecPay. In other words, Becker earned more than 55.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,228 out of 13,971 | 55th |
Division Manufacturing | 2,338 out of 5,701 | 59th |
Major group Chemicals And Allied Products | 852 out of 2,200 | 61st |
Industry group Drugs | 719 out of 1,886 | 62nd |
Industry Pharmaceutical Preparations | 533 out of 1,398 | 62nd |
Source: SEC filing on April 28, 2020.
Becker's colleagues
We found two more compensation records of executives who worked with Marc Becker at Concert Pharmaceuticals in 2019.